Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Administrator Selection Buzz Gathers Steam As Health Reform Stalls

This article was originally published in The Pink Sheet Daily

Executive Summary

It may no longer make sense for the administration to wait for a reform bill to pass before announcing a nominee.

You may also be interested in...



CMS Names Tavenner Principal Deputy Administrator, Proposes Reorg

CMS in an internal e-mail announced proposed changes to its management structure, including the establishment of the position of principal deputy administrator and the consolidation and integration of various agency functions. The agency's goal is to better focus on three key areas: beneficiary services, program integrity and strategic planning

CMS Names Tavenner Principal Deputy Administrator, Proposes Reorg

CMS in an internal e-mail announced proposed changes to its management structure, including the establishment of the position of principal deputy administrator and the consolidation and integration of various agency functions. The agency's goal is to better focus on three key areas: beneficiary services, program integrity and strategic planning

CMS Names Tavenner Principal Deputy Administrator, Proposes Management Reorg

Internal e-mail notes that Charlene Frizzera will continue on as acting administrator and COO.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS070300

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel